The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and ...

The U.S. Capitol in Washington, DC. A bipartisan group of lawmakers has reintroduced legislation to allow immediate expensing of research and development costs, all the way back to 2022 when the tax ...

Eli Lilly & Co.’s shares fell 6% early Thursday after the drugmaker cut its full-year earnings outlook citing research costs and CVS Health Corp. announced a deal to make its rival’s weight-loss drug ...

Under the TCJA, for tax years beginning after December 31, 2021, Section 174 provided that expenditures incurred in connection with research and development activities, including all costs incident to ...

Two months after the National Institutes of Health unilaterally capped indirect research cost reimbursement rates at 15 percent—which a federal judge has permanently blocked—the Department of Energy ...

For decades, America’s drug-price debate has centered on a fundamental tension: How do policymakers encourage expensive research and development, while ensuring that companies keep final prices ...

The Food and Drug Administration is relaxing regulations on biosimilar drugs used for cancer and rare diseases in the hopes of boosting competition and lowering prices for high-cost pharmaceuticals.

Clinical trials are facing a crisis amid growing delays, diminishing success rates and rising costs. Companies across the stakeholder spread are investing in AI to ease some of the longstanding ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...